Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enlivex Ltd. - Ordinary Shares (NQ:ENLV)

1.280 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	343,342
Open	1.270
Bid (Size)	1.300 (200)
Ask (Size)	1.360 (500)
Prev. Close	1.280
Today's Range	1.200 - 1.310
52wk Range	1.150 - 27.15
Shares Outstanding	18,306,186
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

July 30, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

July 29, 2026

From Enlivex Ltd.

Via GlobeNewswire

Performance

YTD	-88.7%	-88.7%
1 Month	-41.0%	-41.0%
3 Month	-90.0%	-90.0%
6 Month	-92.4%	-92.4%
1 Year	-91.9%	-91.9%

More News

These stocks are moving in today's session ↗

July 28, 2026

Via Chartmill

Top stock movements in today's session. ↗

July 28, 2026

Via Chartmill

Which stocks are gapping on Tuesday? ↗

July 28, 2026

Via Chartmill

Which stocks are moving before the opening bell on Tuesday? ↗

July 28, 2026

Via Chartmill

Enlivex Announces $400,000,000 Private Placement

July 28, 2026

From Enlivex Ltd.

Via GlobeNewswire

What's going on in today's pre-market session ↗

July 20, 2026

Via Chartmill

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

July 20, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis

July 13, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

July 07, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume

June 24, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

June 22, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis

June 15, 2026

From Enlivex Ltd.

Via GlobeNewswire

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

June 02, 2026

From Enlivex Ltd.

Via GlobeNewswire

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

June 01, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board

May 28, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

May 27, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

May 18, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification

May 15, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

April 30, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million

April 28, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress

April 23, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

April 21, 2026

From Enlivex Ltd.

Via GlobeNewswire

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025

March 26, 2026

Via NewMediaWire

Frequently Asked Questions

Is Enlivex Ltd. - Ordinary Shares publicly traded?

Yes, Enlivex Ltd. - Ordinary Shares is publicly traded.

What exchange does Enlivex Ltd. - Ordinary Shares trade on?

Enlivex Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Enlivex Ltd. - Ordinary Shares?

The ticker symbol for Enlivex Ltd. - Ordinary Shares is ENLV on the Nasdaq Stock Market

What is the current price of Enlivex Ltd. - Ordinary Shares?

The current price of Enlivex Ltd. - Ordinary Shares is 1.280

When was Enlivex Ltd. - Ordinary Shares last traded?

The last trade of Enlivex Ltd. - Ordinary Shares was at 09/01/26 04:00 PM ET

What is the market capitalization of Enlivex Ltd. - Ordinary Shares?

The market capitalization of Enlivex Ltd. - Ordinary Shares is 23.43M

How many shares of Enlivex Ltd. - Ordinary Shares are outstanding?

Enlivex Ltd. - Ordinary Shares has 23M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.